MAKO Surgical talks about some uncertainties in the wake of Hurricane Sandy.
A close look at the books at Dendreon.
Questcor makes a push for a new indication.
Can a coming spinoff help increase margins?
Express Scripts is losing a big customer in UnitedHealth.
Will da Vinci be dethroned by Mozart?
UnitedHealth looks to save costs by insourcing.
Things might not be as bad as feared.
There's only one reason to buy a stock.
Will hepatitis C be the key to Abbvie's future?
Shares slammed after FDA panel vote.
The outlook for Heplisav doesn't look too rosy.
Are all medical robots created equal? No.
It's raising $40 million in capital by selling stock -- what it means for you.
Screening changes weigh on Intuitive's growth
It recently received clearance for a new instrument for surgical stapling.
MAKO taps the market with a secondary offering.
Perfection is unattainable, right?
London conference commentary supports a strong 62-week release.
Another one bites the dust.